Journal
INTERNATIONAL JOURNAL OF EATING DISORDERS
Volume 44, Issue 3, Pages 269-275Publisher
WILEY
DOI: 10.1002/eat.20807
Keywords
anorexia nervosa; bulimia nervosa; atypical antipsychotics; aripiprazole; long-term follow up; dopamine
Ask authors/readers for more resources
Objective: There has been much interest in the use of atypical antipsychotics in anorexia nervosa (AN). However, newer, more weight-neutral medications have not been studied in AN, and there are no reports of the use of antipsychotics in bulimia nervosa (BN). Method: We report on the treatment of eight patients (five with AN and three with BN) with aripiprazole for time periods of four months to more than three years. Results: All individuals had reduced distress around eating, fewer obsessional thoughts about food, weight and body image, significant lessening of eating-disordered behaviors, and gradual weight restoration where appropriate. Depression, generalized anxiety, and cognitive flexibility improved as well. Discussion: In summary, these findings support the need to perform controlled trials of aripiprazole in AN and BN. (C) 2010 by Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available